Authors: de Wilt, JHW Manusama, ER van Etten, B van Tiel, ST Jorna, AS Seynhaeve, ALB ten Hagen, TLM Eggermont, AMM

Citation: Jhw. De Wilt et al., Nitric oxide synthase inhibition results in synergistic anti-tumour activity with melphalan and tumour necrosis factor alpha-based isolated limb perfusions, BR J CANC, 83(9), 2000, pp. 1176-1182

Authors: de Roos, WK de Wilt, JHW van der Kaaden, ME Manusama, ER de Vries, MW Bout, A ten Hagen, TLM Valerio, D Eggermont, AMM

Citation: Wk. De Roos et al., Isolated limb perfusion for local gene delivery - Efficient and targeted adenovirus-mediated gene transfer into soft tissue sarcomas, ANN SURG, 232(6), 2000, pp. 814-820

Authors: Manusama, ER De Wilt, JHW Ten Hagen, TLM Marquet, RL Eggermont, AMM

Citation: Er. Manusama et al., Toxicity and antitumor activity of interferon gamma alone and in combinations with TNF alpha and melphalan in isolated limb perfusion in the BN175 sarcoma tumor model in rats, ONCOL REP, 6(1), 1999, pp. 173-177

Authors: Bickels, J Manusama, ER Gutman, M Eggermont, AMM Kollender, Y Abu-Abid, S Van Geel, AN Lev-Shlush, D Klausner, JM Meller, I

Citation: J. Bickels et al., Isolated limb perfusion with tumour necrosis factor-alpha and melphalan for unresectable bone sarcomas of the lower extremity, EUR J SUR O, 25(5), 1999, pp. 509-514

Authors: de Wilt, JHW Manusama, ER van Tiel, ST van Ijken, MGA ten Hagen, TLM Eggermont, AMM

Citation: Jhw. De Wilt et al., Prerequisites for effective isolated limb perfusion using tumour necrosis factor alpha and melphalan in rats, BR J CANC, 80(1-2), 1999, pp. 161-166